The Food and Drug Administration (FDA) is cracking down on companies that manufacture and distribute nicotine-containing e-liquids with labeling that appears to imitate that of prescription cough syrups.
The Food and Drug Administration (FDA) is notifying the public that cases of seizures have been reported following the use of e-cigarettes.
There is considerable concern regarding the potential negative impact that electronic cigarettes and other new products may have on ending all tobacco use and nicotine addiction.
Most who smoke cigarettes and e-cigs have smoke-free home policies; fewer have vape-free policies
Water pipe tobacco smokers are exposed to level of nicotine that is physiologically active in short term
Assuming causality, 22 percent of SUIDs directly attributed to maternal smoking during pregnancy
Prevalence of chronic kidney disease, CKD development increased with exposure to secondhand smoke
Gottlieb’s signature effort has been tighter scrutiny, enforcement of e-cigarette industry
Results from a placebo-controlled study evaluating Chantix (varenicline; Pfizer) in pediatric patients 12-16 years of age showed that the smoking cessation treatment was not associated with a significant increase in abstinence rates in this patient population.
One-year abstinence higher with e-cigarettes than other nicotine replacement products
